


Asginase 5000IU Injection
Written By Dr. Syeda Aafia, MBA, BDS,
Reviewed By Dr. Rajeev Sharma, MBA, MBBS,
Last updated on 14 Oct 2026 | 02:04 PM (IST)



₹841
Save more with additional offers







General Information
Contains
Marketer
Storage



Product introduction
Asginase 5000IU Injection is given as an injection into a muscle or as an intravenous infusion (drip) under the supervision of a healthcare professional. Your doctor will determine the dose and treatment schedule based on your body size, condition, and response to treatment. Regular monitoring is required to assess how well the medicine is working and identify any side effects. Do not miss scheduled treatment appointments or stop treatment without consulting your doctor.
Common side effects of this medicine include nausea, vomiting, diarrhea, abdominal pain, fatigue, and decreased appetite. It may also cause increased blood sugar levels, liver problems, and inflammation of the pancreas (pancreatitis). Your doctor will monitor your blood sugar levels, liver function, and pancreatic function during treatment. Inform your doctor immediately if you experience severe abdominal pain, persistent vomiting, or unusual symptoms.
Asginase 5000IU Injection may cause serious allergic reactions, bleeding problems, or blood clots. Inform your doctor if you have previously experienced severe allergic reactions, pancreatitis, blood clots, or serious bleeding during asparaginase treatment. Seek immediate medical attention if you develop breathing difficulties, swelling of the face, unusual bleeding, or sudden chest pain.
Before receiving this medicine, inform your doctor if you are pregnant, planning to become pregnant, or breastfeeding. Both men and women should use effective contraception during treatment and for at least 3 months after the last dose. Breastfeeding should be avoided during treatment and for 2 weeks after the last dose.
Uses of Asginase Injection
- Blood cancer (Acute lymphocytic leukemia)
Benefits of Asginase Injection
Acute lymphocytic leukemia (ALL) is a type of blood cancer in which abnormal white blood cells multiply rapidly and interfere with the production of healthy blood cells. Asginase 5000IU Injection is an anticancer medicine used alongside other chemotherapy medicines to help destroy these abnormal cells and control the disease. It plays an important role in combination chemotherapy and helps patients continue their planned treatment.
Side effects of Asginase Injection
- Vomiting
- Febrile neutropenia
- Nausea
- Increased transaminase level in blood
- Abdominal pain
- Increased white blood cell count
- Diarrhea
- Decreased white blood cell count (lymphocytes)
How to use Asginase Injection
How Asginase Injection works
All substitutes for Asginase 5000IU Injection
Lagicad 5000IU Injection
L Aspinase 5000IU Injection
Leucoginase 5000IU Injection
Onconase 5000IU Injection
L-Aspase 5000IU Injection
Quick tips
- Asginase 5000IU Injection is given as an injection into a muscle or as an intravenous infusion by a healthcare professional. Attend all scheduled appointments to avoid interruptions in your chemotherapy treatment.
- Report severe or persistent abdominal pain, especially if accompanied by nausea, vomiting, or back pain. These symptoms may indicate inflammation of the pancreas (pancreatitis).
- Get your blood sugar levels checked regularly, as Asginase 5000IU Injection may cause high blood sugar. Inform your doctor if you experience unusual thirst, frequent urination, or other symptoms of high blood sugar.
- Attend regular blood tests to monitor your liver function and pancreatic health. These tests help your doctor identify potential side effects and manage them promptly.
- Avoid driving or operating heavy machinery if you experience nausea, headache, or feel unwell after receiving the medicine.
- Both men and women should use effective contraception during treatment and for at least 3 months after the last dose. Women should discuss suitable non-hormonal contraceptive methods with their doctor.
- Avoid breastfeeding during treatment and for at least 2 weeks after the last dose, as the medicine may pose a risk to the breastfed baby.
Safety advice

Alcohol

Pregnancy

Breast feeding

Driving

Kidney

Liver
It should not be used in severe liver impairment.
Interaction with drugs
Imatinib mesylate (Oral Route)
Acarbose (Oral Route)
Alogliptin (Oral Route)
Bemiparin (Injection Route)
Bevacizumab (Injection Route)
Frequently asked questions
Fact Box
Chemical Class
Habit Forming
Therapeutic Class
Action Class
Related lab tests
References
- Chabner BA, Bertino J, Cleary J, et al. Cytotoxic Agents. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. pp. 1720-21.
- Chu E, Sartorelli AC. Cancer Chemotherapy. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. p. 956.
- Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. p. 88.
- L-Asparaginase [Summary of Product Characteristics]. Dublin, Ireland: Jazz Pharmaceuticals Ireland Ltd.; 2023. [Accessed 10 Oct. 2026] (online). Available from:
- Asparaginase [Summary of Product Characteristics]. Wedel, Germany: Medac; 2020. [Accessed 10 Oct. 2026] (online). Available from:
- CDSCO: Manufacturing and Marketing permission issued from SND Division from 01.01.2016 to till date. [Accessed 14 Oct. 2026] (online). Available from:




Want to know more
We provide you with authentic, trustworthy and relevant informationHave issue with the content
Disclaimer
Marketer details
Address: Plot no 107/108,Namli block , Ranipool, East Sikkim 737135 || Khasra No. 1335-1340,Near EPIP- I, Vill - Bhatoli Kalan ,Baddi, Solan, Himachal Pradesh, 173205 || Acme Plaza, Andheri-Kurla Road, Andheri (East), Mumbai, Maharashtra -400059
Vendor Details
Lab tests offered by us
- CBC (Complete Blood Count)
- FBS (Fasting Blood Sugar)
- Thyroid Profile Total (T3, T4 & TSH)
- HbA1c (Glycosylated Hemoglobin)
- PPBS (Postprandial Blood Sugar)
- Lipid Profile
- Vitamin D (25-Hydroxy)
- Urine R/M (Urine Routine & Microscopy)
- Coronavirus Covid -19 test- RT PCR
- LFT (Liver Function Test)
- KFT (Kidney Function Test)
- TSH (Thyroid Stimulating Hormone) Ultrasensitive
- ESR (Erythrocyte Sedimentation Rate)
- Uric Acid, Serum
- Vitamin B12
- CRP (C-Reactive Protein), Quantitative
- Urine C/S (Urine Culture and Sensitivity)
- Serum Electrolytes
- Serum Calcium
- Serum Creatinine
- Diabetes Screening (HbA1C & Fasting Sugar)
- KFT with Electrolytes (Kidney Function Test with Electrolytes)
- Cholesterol - Total
- Hb (Hemoglobin)
- Complete Hemogram (CBC & ESR)















